BCMA-targeted and CAR-T cells therapies for multiple myeloma give a very exciting future and new hope for the patients
In this MEDtalk, Sagar Lonial, Chief Medical Officer, Winship Cancer Institute of Emory University, USA, gives his perspective on the explosion of new BCMA-targeted immune therapies and CAR-T cell therapies with encouraging data. These new treatment targets raise the question of how to sequence treatment. In this MEDtalk, you will get a fresh perspective from one of the leading experts.
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.